Daily Delivery and Supervision of Psychotropic Medication for High-Risk Patients With Severe/Persistent Mental Illness

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 15, 2016

Primary Completion Date

December 30, 2018

Study Completion Date

February 11, 2019

Conditions
Medication Adherence
Interventions
OTHER

Daily

The main study intervention is the daily witnessing of participants while they self-administer their medications by trained pharmacy staff to ensure compliance. The staff in question will be provided by Leila pharmacy and will in addition provide support so that individuals can transition back into living independently through reminders to attend regularly scheduled medical appointments and counseling on correct use of prescribed medications.

Trial Locations (1)

Unknown

University of Manitoba, Winnipeg

All Listed Sponsors
collaborator

Winnipeg Regional Health Authority

OTHER

lead

University of Manitoba

OTHER

NCT03766503 - Daily Delivery and Supervision of Psychotropic Medication for High-Risk Patients With Severe/Persistent Mental Illness | Biotech Hunter | Biotech Hunter